Large white/landrace piglets (mass 11 to 21 kg) were exposed to aerosolized alkaline glycine diluent (n=2) or inhaled aerosolized prostacyclin (n=2) for five to eight hours. Pigs receiving these aerosols developed mild acute sterile tracheitis, involving the superficial layers of the trachea, shown histologically and ultrastructurally. Pigs receiving the diluent aerosol also showed mild inflammatory changes in the bronchioles. These findings suggest caution with the use of high volumes of aerosolized alkaline glycine diluent during inhaled aerosolized prostacyclin therapy. FIGURE 1: Aerosol delivery system for piglets. A=syringe pump. B=jet nebuliser. C=nebuliser driving gas. D=catheter mount. E=anaesthesia machine.
Prostacyclin (PGI 2 ) is an endogenously-produced potent vasodilator which has a duration of action of one to three minutes 1 . Its other major effect is platelet inhibition, mediated by an increase in cyclic adenosine monophosphate (c-AMP) [1] [2] [3] [4] . Synthetic PGI 2 (epoprostenol, Flolan, GlaxoWellcome, Boronia, Vic., Australia) has been used therapeutically as an intravenous vasodilator and anticoagulant 2, 5 . More recently, PGI 2 has emerged as a selective pulmonary vasodilator (SPV) for conditions where hypoxaemia and pulmonary hypertension are part of the pathophysiological spectrum, such as the acute respiratory distress syndrome (ARDS) [6] [7] [8] .
When delivered to patients as inhaled aerosolized prostacyclin (IAP), PGI 2 meets the criteria for pulmonary selectivity. The active drug is delivered to ventilated lung units, improving ventilationperfusion (V . / . Q) matching and thereby oxygenation 9 .
Also, because of the short duration of action of the drug and the small doses (nanograms) delivered to the pulmonary vasculature, there is no systemic hypotension associated with its administration 10 .
These features make IAP therapy a viable alternative to nitric oxide (NO) as a SPV, with the advantage that it is technically much simpler to administer IAP 11 .
Nevertheless, the potential pulmonary toxicity of IAP has not been fully investigated. Several studies have examined the pulmonary and systemic haemodynamic consequences of IAP administration 6, 7, [12] [13] [14] [15] [16] [17] [18] [19] [20] . However, none has addressed one of the main concerns of IAP therapy, namely the high alkalinity (pH ~10.5) of the glycine buffer in which PGI 2 is dissolved prior to administration. This alkaline solution applied directly to lung tissue is potentially irritant.
This observational study was designed to investigate the presence of pulmonary inflammatory changes (as defined by pulmonary neutrophil infiltration) in anaesthetized piglets exposed to high-dose IAP administration for up to eight hours.
MATERIALS AND METHODS

Animals
Animal Experimentation Ethics Committee (of the University of Western Australia) approval was obtained prior to commencement of the study. Four large white/landrace cross piglets with a mass of up to 25 kg were studied. The piglets were anaesthetized by inhalational induction with halothane 3% to 5% in oxygen. Intubation of the trachea was performed, without the use of muscle relaxants, with a 6 mm cuffed endotracheal tube. Anaesthesia was maintained with halothane (0.5 to 1%) in oxygenenriched air (FiO 2 0.4 to 0.5) and intravenous pentobarbitone infused at 8 mg/kg/h. The piglets breathed spontaneously. Monitoring consisted of: -continuous invasive arterial blood pressure via a femoral artery catheter, -continuous pulse oximetry (SpO 2 ) and -hourly rectal temperature recordings.
Normal saline solution (0.9% sodium chloride) was infused to maintain hydration via a femoral venous catheter at 2 ml/kg/h, using a volumetric infusion pump (IMED Gemini PC-1, Imed Corp., U.S.A.). The piglets were turned from side to side every two hours during the study period to minimize the effects of pulmonary atelectasis and other positional effects.
Aerosol therapy
Aerosol therapy was delivered using a Sidestream jet nebulizer (Medic-Aid Ltd, U.K.). This nebulizer produced saline particles with a mass median diameter (MMD) of 3.19 microns and glycine buffer diluent (in which PGI 2 is dissolved prior to delivery) particles with a MMD of 3.38 microns as measured by laser particle analyser 21 .
The continuous delivery of aerosol into the breathing circuit is depicted in Figure 1 . Syringe pump "A" pumped either glycine buffer diluent (glycine in saline 0.147% weight for volume) or prostacyclin solution (PGI 2 10 µg/ml dissolved in glycine buffer diluent) into the nebulizer "B" at 15 ml/h, the maximum rate at which the Sidestream nebulizer was able to produce aerosol. The piglets breathed from the breathing circuit attached at the catheter mount "D". The nebulizer was driven by a gas supply "C" at 6 l/min, delivered at 420 kiloPascals. Continuous aerosol therapy was administered for 5 to 8 hours.
The piglets were assigned to two groups:
-Diluent (D) treated animals (n=2) -The two pigs (21 kg and 13.5 kg) in this group received aerosol therapy (for 7 to 8 hours) with only alkaline glycine diluent. The rate of aerosolization was 15 ml/h. -Prostacyclin (P) group (n=2) -The two pigs in this group (14 kg and 11 kg) received IAP (10 µg/ml) at 15 ml/h (for 5 to 7 hours). A ventilation scan was carried out on a fifth piglet to validate the aerosol delivery system. Radiolabelled DTPA was dissolved in the glycine buffer diluent prior to aerosolization. This solution was delivered to the piglet using a system similar to that depicted in Figure 1 . The ventilation scan is shown in Figure 2 .
Pathology
At the end of the aerosol therapy, all pigs were sacrificed with a lethal intravenous dose of pentobarbitone. The trachea and both lungs were removed from all four pigs by median sternotomy and sent to the pathology laboratory en-bloc. Sputum samples were collected via tracheal suction for bacteriological assessment of possible infection. The tissue samples from each pig were coded according to treatment and were sent for pathology without disclosure of treatments (i.e., pathologists were blinded as to treatment group).
Portions of tissue were taken for light microscopic and ultrastructural examination by using sharp-edged razor blades to maintain the integrity of the tissue as follows.
-One cross-sectional slice of trachea from each animal was taken a maximum of one centimetre above the carina, to avoid areas of mechanical trauma due to intubation. -One cross-section of the right and left main stem bronchus were taken. -Sections of anterior and posterior aspects of parenchyma from medial and median sagittal slices of the right and left lung, and one section from a lateral slice of each lung were taken as shown schematically in Figure 3 . A total of five areas of parenchyma were biopsied from each of the right and left lung of each pig.
Light microscopy
Biopsies for light microscopy were immediately immersed in 10% buffered formal saline and fixed for at least 24 hours. The tissue was processed though increasing grades of alcohol and embedded in paraffin wax. Six micron sections were stained with Harris haematoxylin and 1% alcoholic eosin and examined by light microscopy. Each section was examined for the presence of polymorphonuclear leucocytes (PMNs). The degree of PMN infiltration was graded as follows- Five individual, randomly selected fields (400x magnification) from each trachea and each right and left main stem bronchus from each pig were analysed. Grading of each field of view was performed according to the numbers of PMNs counted within the lining epithelium (excluding the lumen), the lamina propria and the submucosa (of each trachea and main stem bronchus).
With respect to analysis of the bronchioles (the distal airways), PMNs within the epithelium, lamina propria and submucosa of 20 randomly selected bronchiolar cross sections were examined in each section of lung parenchyma (400x magnification). A total of 200 individual bronchioles were examined for each pig (5 fields in each of 4 quadrants in each of 5 sections from each lung).
Grading of the numbers of PMNs found within the interstitium (including alveoli and capillaries and excluding bronchi and bronchioles) of each pig lung was performed by bisecting two (400x magnification) fields with a marker in 5 regions of each lung specimen obtained. the upper edge of the opaque marker bar were counted. Thus a total of 100 interstitial measurements were taken for each pig (2 fields in each of 5 quadrants in each of 5 specimens from each lung).
Electron microscopy
Tissue slices up to a maximum of 3 mm in thickness were immediately immersed in a freshly prepared fixative solution comprising 4% paraformaldehyde and 5% glutaraldehyde in 0.2M cacodylate buffer, pH 7.4 for 24 hours. The samples were post-fixed in 1% osmium tetroxide, dehydrated in increasing grades of ethanol and embedded in araldite. Semi-thin sections (0.5 to 1 µm) of each sample were stained with 0.2% toluidine blue in 5% borax and viewed by light microscopy. Representative ultrathin sections (50 to 90 nm) of the samples were then cut, mounted on 200 mesh copper grids, contrast enhanced with lead citrate and uranyl acetate solutions and viewed with a Philips 410 transmission electron microscope (Philips, The Netherlands).
As well as the PMN count as described above, the light microscope slides and electron micrographs were reviewed by an independent pathologist for signs of acute inflammation.
RESULTS
Mean arterial pressure, heart rate, temperature and arterial oxygen saturation (SpO 2 ) remained within normal limits thoughout the study period in all pigs.
Pathology
The summary histological grades (0 to 3) by site are tabulated in Table 1 .
Blinded independent review of the pathology slides confirmed mild acute tracheitis in all the animals in both the D and P groups. The main bronchi and bronchioles were minimally involved. Changes were confined to the superficial layers (epithelium and lamina propria) of the trachea. These findings were not associated with positive sputum cultures. As can be seen in Table 1 , the histological grade at each site was very low.
Independent blinded review of the electron micrographs showed: -Group P piglet (14 kg) showed evidence of PMN infiltration of the epithelium and lamina propria of the trachea, as well as fluid exudation in these areas. There were PMNs present in the submucosa. PMNs were also readily seen in the small vessels (Figure 4 ). -Group P piglet (11 kg) showed occasional PMNs in the tracheal epithelium ( Figure 5) , with accumulations of PMNs in the lamina propria and the submucosa.
There was no other evidence on electron microscopy of acute inflammation at any of the other sites, in any of the other pigs.
DISCUSSION
This observational study showed that administration of aerosols of the alkaline glycine buffer alone 164 P. V. VAN (used to dilute prostacyclin) and of prostacyclin solution (dissolved in the glycine buffer) are associated with mild acute tracheitis. This statement is based on the histological findings described above. The ventilation scan confirmed a high concentration of tracer over the trachea (Figure 2 ). This effect was due to "rain-out" of aerosol particles in the large airways. This could explain the predominance of the PMN infiltration at this site. The tracheitis was sterile (no growth on sputum culture), supporting the diagnosis of chemical inflammation of the trachea. Also, the changes were predominantly in the epithelium and lamina propria layers, indicating a response to an irritant on the luminal surface of the trachea. The histological findings of mild acute tracheitis were supported by ultrastructural changes (Figures 4 and 5) . These findings must be interpreted in the light of the only two other studies that examine the pulmonary toxicity of IAP therapy 22, 23 . In these studies, small numbers of lambs were exposed to IAP therapy for up to eight hours before the lungs were examined for evidence of inflammation. In the first study 22 , the animals' lungs were lavaged and examined for inflammatory cells and mediators following exposure to IAP therapy. No evidence of inflammation was found. In the second study, by the same investigators 23 , the lungs were removed and examined by light and electron microscopy for evidence of inflammation. Again, no evidence was found. Both studies employed doses and volumes of IAP appropriate to the clinical treatment of humans 23 (28 ng/kg/min).
The sample size (n=4) of the current study is smaller than the other animal studies (n=14) 23, 24 . The current study demonstrated the presence of only mild superficial acute tracheitis in pigs exposed to short-term glycine diluent aerosol or IAP. The aerosols in this study were administered at approximately nine times the maximum volume/dose of diluent (on a dose/mass basis) that would be given to an adult human during IAP therapy. An adult receiving a prostacyclin dose of 50 ng/kg/min (the maximum dose administered to any patient therapeutically by the authors) during IAP therapy would require only approximately 5 ml/h of prostacyclin solution (50 µg/ml concentration). Therefore, such a subject would also only receive 5 ml/h of alkaline diluent aerosol. Similar doses in the previously-mentioned animal studies above 23, 24 did not result in pulmonary inflammatory changes. Doses and volumes of aerosol therapy used in the current study were intentionally high to maximize a treatment effect if it existed, but do not bear direct relationship to the clinical setting. The significance and natural history of the PMN infiltration described in this study are not known.
There may also be significant inter-species variation in the degree of inflammation mounted in response to exposure to the alkaline diluent 22, 23 . In all the reported literature to date on IAP therapy, there are no reports of inflammation of the airways in the human subject.
IAP therapy is only used in hypoxaemic patients with ARDS as a rescue therapy when oxygenation is not possible by conventional means. This is done in order to reduce lung toxicity from exposure to high inspired concentrations of oxygen. Administration of IAP in this circumstance is then given on the principle of "balance of risks" (risk of toxicity of IAP therapy versus risk of oxygen toxicity). The findings in this study suggest caution in the administration of high volumes of aerosolized glycine diluent during IAP therapy. The two other animal studies 22, 23 contradict the findings of this study, as does the well-documented, widespread, safe use of IAP in humans 1, 2, 5, [7] [8] [9] [10] 12, [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] . IAP has also been given safely to healthy volunteers 2, 5 . Therefore, particularly in light of the low histological grade of the PMN infiltration found in response to aerosolized alkaline diluent or prostacyclin solution (Table 1) , we continue to use IAP therapeutically. It should also be noted that the findings in this study were of PMN infiltration, with no evidence of tissue destruction. The smallest practical volumes of glycine diluent are used for the solution and delivery of IAP, when administered to critically ill patients with ARDS.
CONCLUSION
High doses of alkaline glycine diluent and prostacyclin solution delivered as aerosols to anaesthetized pigs were associated with the development of mild acute tracheitis. These findings suggest that the smallest practical volumes of alkaline diluent buffer should be delivered to patients receiving IAP therapy.
